SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details) - $ / shares |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Exercise Price | $ 1.72 | $ 1.72 | $ 1.23 |
| Number Outstanding | 780,000 | 780,000 | 2,415,000 |
| Number Exercisable | 780,000 | ||
| Stock Option One [Member] | |||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Exercise Price | $ 1.00 | ||
| Number Outstanding | 500,000 | ||
| Weighted Average Remaining Contractual Life | 5 years 8 months 12 days | ||
| Number Exercisable | 500,000 | ||
| Stock Option Two [Member] | |||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Exercise Price | $ 3.00 | ||
| Number Outstanding | 280,000 | ||
| Weighted Average Remaining Contractual Life | 1 year 9 months 18 days | ||
| Number Exercisable | 280,000 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|